| Literature DB >> 22489160 |
Chen-Chen Wu1, Xiao-Bing Li1, Tie-Suo Han1, Peng Li1, Guo-Wen Liu1, Wei-Zhong Wang2, Zhe Wang1.
Abstract
The objective of our study was to evaluate whether feeding pseudopurpurin affects bone mineral density and bone geometry architecture in rats. Pseudopurpurin was extracted, analyzed and purified using an HLPC-ESI-MS. Rats were given 0% and 0.5% pseudopurpurin powder in their diet. Femurs of rats were examined at 0.5, 1 and 2 months after pseudopurpurin feeding. Compared with rats in the group 0%, the bone mineral density, and the calcium, magnesium, zinc and manganese concentrations in the rats femur in the group 0.5% increased significantly at 1 month and 2 months after pseudopurpurin feeding. Analytical results of micro-computed tomography showed that the group 0.5% displayed an increase in the trabecular volume fraction, trabecular thickness and trabecular number of the distal femur at 1 and 2 months after pseudopurpurin feeding, and the mean thickness, inner perimeter, outer perimeter, and area of the femur diaphysis were significantly increased at 2 months after pseudopurpurin feeding compared with the group 0%. In parallel, the trabecular separation and structure model index of the distal femur were decreased, compared with the group 0% at 1 and 2 months after pseudopurpurin feeding. In the 0.5% and 0% groups, there was no damage to kidney and liver by histopathology analysis. The long-term feeding of pseudopurpurin is safe for rats. The feeding of 0.5% pseudopurpurin which has specific chemical affinities for calcium for bone improvement and level of bone mineral density, enhances the geometry architecture compared with the 0% group.Entities:
Keywords: bone geometry architecture; bone mineral density; bone mineral elements; pseudopurpurin
Mesh:
Substances:
Year: 2012 PMID: 22489160 PMCID: PMC3317720 DOI: 10.3390/ijms13033431
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 6.208
Figure 1Negative-ion mass spectra of pseudopurpurin obtained by LC-ESI-MS analysis of an extract of madder powder.
Body weight and femur length of rats at 0.5, 1 and 2 months after pseudopurpurin feeding.
| Body weight (g) | Femur length (cm) | ||
|---|---|---|---|
| 0.5% group | 0.5 month | 24.5 ± 5.66 | 0.81 ± 0.057 |
| 1 month | 57.3 ± 9.37 | 1.78 ± 0.72 | |
| 2 months | 123.6 ± 22.2 | 2.12 ± 0.92 | |
| 0% group | 0.5 month | 23.8 ± 6.01 | 0.79 ± 0.034 |
| 1 month | 54.6 ± 11.57 | 1.55 ± 0.83 | |
| 2 months | 116 ± 21.5 | 1.94 ± 0.94 |
Figure 2The level of bone mineral composition and bone mineral density in the rat femur in the groups 0% and 0.5% at 0.5, 1 and 2 months after pseudopurpurin feeding. Data are expressed as the means ± SD; * P < 0.05 versus the group 0%.
Figure 3Liver sections of the group 0.5% (a) and the group 0% (b) and kidney sections of the group 0.5% (c) and the group 0% (d) are shown (hematoxylin and eosin (stain), 100×).
Comparison of the biochemical levels in blood plasma of rats in 0.5% and 0% groups at 2 months after pseudopurpurin feeding.
| AST (U/L) | ALT (U/L) | BUN (mmol/L) | CRE (umol/L) | |
|---|---|---|---|---|
| 0.5% group | 82.40 ± 5.47 | 31.24 ± 3.17 | 11.52 ± 1.44 | 22.38 ± 1.44 |
| 0% group | 83.24 ± 5.99 | 31.45 ± 2.66 | 10.79 ± 1.24 | 21.02 ± 1.54 |
Data are expressed as the means ± SD;
Figure 4(a) Three-dimensional images of the distal femur in rats in the 0.5% group at 0.5, 1 and 2 months after pseudopurpurin feeding. (b) Three-dimensional images of the distal femur in rats in the 0% group at 0.5, 1 and 2 months after pseudopurpurin feeding. (c) Three-dimensional images of the femur diaphysis in rats in the 0.5% group at 0.5, 1 and 2 months after pseudopurpurin feeding. (d) Three-dimensional images of the femur diaphysis in rats in the 0% group at 0.5, 1 and 2 months after pseudopurpurin feeding.
3-D micro-structural properties of the distal femur in rats in groups 0.5% and 0%.
| BV/TV (%) | Tb.Th (mm) | Tb.N (/mm) | Tb.Sp (um) | SMI | ||
|---|---|---|---|---|---|---|
| 0% group rats | 0.5 month | 2.32 ± 0. 3 | 0.051 ± 0.009 | 2.76 ± 0.58 | 0.365 ± 0.03 | 2.22 ± 0.3 |
| 0.5% group rats | 2.38 ± 0.5 | 0.054 ± 0.01 | 2.77 ± 0.69 | 0.370 ± 0.037 | 2.20 ± 0.4 | |
| 0% group rats | 1 month | 3.16 ± 0.04 | 0.08 ± 0.007 | 3.16 ± 1.11 | 0.295 ± 0.013 | 1.92 ± 0.03 |
| 0.5% group rats | 3.82 ± 0.03 | 0.13 ± 0.007 | 4.01 ± 1.07 | 0.216 ± 0.014 | 1.30 ± 0.02 | |
| 0% group rats | 2 months | 5.61 ± 0.08 | 0.15 ± 0.05 | 3.99 ± 1.0 | 0.218 ± 0.003 | 1.41 ± 0.011 |
| 0.5% group rats | 6.75 ± 0.08 | 0.23 ± 0.04 | 5.16 ± 1.3 | 0.167 ± 0.005 | 0.86 ± 0.01 |
Data are expressed as the means ± SD;
P < 0.05 versus 0% group rats.
Bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular number (Tb.N), trabecular separation (Tb.Sp) and structure model index (SMI).
3-D micro-structural properties of the mid-femur diaphysis in rats in groups 0.5% and 0%.
| Mean Thickness (mm) | Inner Perimeter (mm) | Outer Perimeter (mm) | Marrow Area (mm2) | Cortical Area (mm2) | Total Area (mm2) | ||
|---|---|---|---|---|---|---|---|
| 0% group rats | 0.5 month | 0.17 ± 0.03 | 4.21 ± 0.9 | 5.7 ± 1.1 | 2.76 ± 0.08 | 0.71 ± 0.03 | 3.22 ± 0.7 |
| 0.5% group rats | 0.18 ± 0.05 | 4.42 ± 1.0 | 6.34 ± 1.1 | 2.77 ± 0.09 | 0.718 ± 0.037 | 3.20 ± 0.8 | |
| 0% group rats | 1 month | 0.241 ± 0.05 | 6.57 ± 1.0 | 8.28 ± 1.54 | 3.34 ± 0.67 | 1.86 ± 0.36 | 5.33 ± 1.64 |
| 0.5% group rats | 0.267 ± 0.03 | 6.82 ± 0.88 | 8.41 ± 1.33 | 3.54 ± 0.78 | 1.99 ± 0.34 | 5.35 ± 1.55 | |
| 0% group rats | 2 months | 0.38 ± 0.09 | 7.56 ± 1.82 | 10.87 ± 3.1 | 4.01 ± 1.64 | 3.75 ± 1.22 | 7.16 ± 2.31 |
| 0.5% group rats | 0.43 ± 0.07 | 8.41 ± 1.34 | 13.88 ± 2.87 | 5.17 ± 1.77 | 4.8 ± 1.12 | 8.13 ± 2.13 |
Data are expressed as the means ± SD;
P < 0.05 versus 0% group rats.
Figure 5Each test tube showing residual calcium contents depending on the different dose of pseudopurpurin in vitro. Data are expressed as the means ± SD.